Elevance Health Inc. (NYSE: ELV) reported Q3 EPS of $7.53, $0.37 better than the analyst estimate of $7.16. Revenue for the quarter came in at $39.6 billion versus the consensus estimate of $39.26 billion.

GUIDANCE:

Elevance Health Inc. sees FY2022 EPS of $28.95.

For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.